Julia Rotow, MD

Medical Oncology

Julia Rotow, MD

View full profile

Related Videos

ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer Video

ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer

Dana-Farber Cancer Institute's Dr. Julia Rotow reported on a study looking at silevertinib, with data showing it may offer a new first-line option for hard-to-treat EGFR non-small cell lung cancer variants, with encouraging brain activity ...

NSCLC Study Presented by Julia Rotow, MD. Video

NSCLC Study Presented by Julia Rotow, MD.

Dr. Julia Rotow presented results from a study using a cell-free DNA (cfDNA)-guided strategy to personalize first-line treatment for advanced non-small cell lung cancer.